期刊文献+

Strontium ranelate incorporated 3D porous sulfonated PEEK simulating MC3T3-E1 cell differentiation 被引量:1

原文传递
导出
摘要 Polyetheretherketone(PEEK)has been used as an implant material because it has similar mechani-cal properties to natural bone.However,inferior osseointegration and bioinertness hamper the clinical application of PEEK.In this study,the surfaces of sulfonated three-dimensional(3D)PEEK porous structures were loaded with different concentrations of strontium ranelate,a compound commonly used in the treatment or prevention of osteoporosis by promoting bone formation and inhibiting bone resorption.Field-emission scanning electron microscopy was used to characterize the topography of the structures,elemental carbon,oxygen and strontium contents were mea-sured by X-ray photoelectron spectroscopy,and surface zeta potentials and water-contact angle were also measured.The results indicated that strontium ranelate was successfully loaded onto the 3D porous structures.In vitro cellular results showed that strontium ranelate-treated sulfonated PEEK(SP-SR)strengthened the adhesion of MC3T3-E1 cells.The activity of alkaline phosphatase,collagen secretion and extracellular matrix mineralization deposition of MC3T3-E1 cells were also improved on the surface of SP-SR.These results indicate that SP-SR could serve a new implant candidate for surgical treatment.
出处 《Regenerative Biomaterials》 SCIE 2021年第1期43-51,共9页 再生生物材料(英文版)
基金 This study was supported by grants from the National Natural Science Foundation of China(81403029) the Natural Science Foundation of Shanghai(19ZR1449100) the Science and Technology Commission of Shanghai Municipality(19JC1415500) the Science and Technology Commission of Shanghai Municipality(18410760600) the International Partnership Program of Chinese Academy of Sciences(Grant No.GJHZ1850).
  • 相关文献

参考文献10

二级参考文献77

  • 1李雅琳,肖洲生.Runx2基因调控及其异构体的最新研究进展[J].中国药理学通报,2006,22(10):1153-1157. 被引量:7
  • 2An overview of osteoporosis. Lancet 1982; 2: 423-4. 被引量:1
  • 3Yasothan U, Kar S. Osteoporosis: overview and pipeline. Nat Rev Drug Discov 2008; 7: 725-6. 被引量:1
  • 4Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992; 2: 285-9. 被引量:1
  • 5Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423: 337 -42. 被引量:1
  • 6Petrovic O. Estrogen and postmenopausal osteoporosis. Ann Intern Med 1993; 118: 155-6. 被引量:1
  • 7Rizzoli R, Burlet N, Cahall O, Delmas PO, Eriksen EF, Felsenberg 0, et al. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 2008; 42: 841- 7. 被引量:1
  • 8Hong JW, Nam W, Cha IH, Chung SW, Choi HS, Kim KM, et al. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int 2010; 21: 847-53. 被引量:1
  • 9Bush TL, Helzlsouer K. Estrogen replacement therapy and risk of breast cancer. JAMA 1991; 266: 1357 -8. 被引量:1
  • 10Porch N, Lee 1M, Cook NR, Rexrode KM, Burin JE. Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States). Cancer Causes Control 2002; 13: 847 -54. 被引量:1

共引文献85

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部